Iron deficiency is common in women. Menstruation, heavy menstrual bleeding, pregnancy, the postpartum period, blood donation, dietary patterns, gastrointestinal disease and reduced absorption can all contribute. Many women describe the same pattern: haemoglobin is still in the normal range, but energy, concentration, exercise tolerance or hair quality no longer feel normal.
That is clinically important because iron is not only needed for red blood cells. It also supports oxygen transport, mitochondrial function, muscle metabolism, immune function and many enzymes. At the same time, treatment must be precise. Too much iron can be harmful, and intravenous therapy requires a medical benefit-risk decision.
This guide explains what the evidence actually supports: when iron infusions can help women, when oral iron remains appropriate, which blood tests matter and what safety issues should be discussed before treatment.
Why women are commonly affected by iron deficiency
Women of reproductive age lose iron through menstrual bleeding. Heavy or prolonged bleeding increases the risk substantially. Pregnancy and the postpartum period can drain stores because blood volume, the placenta, the fetus and later breastfeeding all change iron needs. Other contributors include blood donation, vegetarian or vegan diets without careful iron planning, coeliac disease, inflammatory bowel disease, chronic inflammation, medication-related absorption issues and previous gastric surgery.
A 2023 JAMA analysis of US females aged 12 to 21 years found that iron deficiency was common, while iron-deficiency anaemia represented only part of the picture. This matters because haemoglobin-only screening may miss women with low iron stores but no anaemia yet: JAMA 2023.
Why anaemia alone is too narrow
JAMA data in US females aged 12 to 21 years, 2003-2020. Values depend on definitions and thresholds but show the scale of the issue.
Iron deficiency was much more common than iron-deficiency anaemia.
Anaemia captures only the more advanced part of the problem.
Symptoms that can fit iron deficiency
Iron deficiency can be associated with fatigue, exhaustion, reduced concentration, lower exercise tolerance, shortness of breath on exertion, dizziness, headaches, palpitations, restless legs, brittle nails and diffuse hair shedding. These symptoms are not specific. Thyroid disease, poor sleep, stress, depression, infection, vitamin deficiencies, cardiovascular disease and other conditions can cause similar symptoms.
The useful clinical question is not: "I am tired, do I need iron?" The better question is: "Do my symptoms, risk factors and laboratory values point to iron deficiency, and which treatment is appropriate?"
The key blood tests: ferritin, transferrin saturation, haemoglobin and CRP
Ferritin reflects iron stores. The World Health Organization describes ferritin as a central marker for assessing iron status and also notes that inflammation changes interpretation. In apparently healthy adults, ferritin below 15 micrograms per litre can indicate iron deficiency; in inflammation, higher thresholds may be needed. The WHO ferritin guideline and ELENA summary explain these cut-offs: WHO Guideline, WHO ELENA.
Transferrin saturation shows how much of the iron transport capacity is loaded with iron. Low values can indicate limited available iron. Haemoglobin shows whether anaemia is already present. CRP helps interpret ferritin because inflammation can make ferritin look higher than the true iron-store situation suggests.
Ferritin
iron stores
Helps estimate whether the body has reserves. In inflammation, interpret with CRP and the full clinical picture.
Transferrin saturation
available iron
Shows whether enough iron is being transported for tissues and blood formation.
Haemoglobin
anaemia status
Essential for diagnosing iron-deficiency anaemia, but not enough to assess iron stores alone.
CRP
inflammation context
Helps identify when ferritin may be distorted by inflammation.
When can an iron infusion make sense?
For iron deficiency, oral iron is often the first step. It is inexpensive, widely available and sufficient for many patients. An infusion becomes more relevant when tablets cause significant gastrointestinal side effects, do not work despite correct use, absorption is impaired, ongoing blood loss empties stores faster than tablets can rebuild them, iron-deficiency anaemia is more pronounced or faster correction is medically justified.
The British Society of Gastroenterology guideline for iron-deficiency anaemia notes that intravenous iron may be preferable from the outset in settings such as significant ongoing bleeding, malabsorption, inflammatory anaemia, problems with administration or poor response to oral therapy: BSG Guideline.
What does the evidence show for fatigue and quality of life?
In iron-deficiency anaemia, iron replacement is standard care. The more nuanced question is whether women with low iron stores but normal or borderline haemoglobin can benefit. Several randomized trials and systematic reviews suggest that iron treatment can reduce self-reported fatigue in selected non-anaemic, iron-deficient women. The effect is not guaranteed, and objective physical-performance measures do not always improve in parallel.
| Source | Population | Finding | Clinical takeaway |
|---|---|---|---|
| PREFER RCT | Women with fatigue, iron deficiency and normal or borderline haemoglobin. | A single ferric carboxymaltose infusion reduced fatigue more than placebo. | IV iron can have meaningful benefit in selected symptomatic women. |
| Blood/ASH RCT | Premenopausal non-anaemic women with ferritin up to 50 ng/ml and fatigue. | IV iron was tested against placebo; stronger effects were reported especially with very low ferritin. | The clearer the deficiency, the more plausible the benefit. |
| BMJ Open Review | Randomized trials of iron therapy in non-anaemic iron deficiency. | Iron reduced self-reported fatigue but did not consistently improve objective physical-capacity measures. | Energy may improve, but athletic performance is not automatically changed. |
| Heavy-menstrual-bleeding Review | Women with heavy menstrual bleeding and iron deficiency or anaemia. | Guidelines recommend diagnosis and treatment of iron deficiency; IV iron is considered depending on severity and clinical context. | If bleeding continues, treating the bleeding source is as important as replacing iron. |
Iron infusion and heavy menstrual bleeding
Heavy menstrual bleeding is one of the most important reasons women repeatedly become iron deficient. An infusion can replenish stores, but it does not treat the bleeding source. If losses continue, values can fall again. That is why heavy, prolonged or changed bleeding should be assessed gynaecologically.
The evidence around heavy menstrual bleeding shows that many guidelines recommend checking blood count and iron status and treating deficiency with oral or intravenous iron depending on severity, tolerance and urgency. IV iron can be especially relevant with iron-deficiency anaemia, upcoming surgery, very low values, tablet intolerance or high ongoing blood loss.
What does the treatment process look like?
The process should begin with the indication, not the infusion. That means reviewing symptoms, laboratory values, possible causes, previous oral iron attempts, allergies, medical conditions, pregnancy status and the suitable formulation and dose.
- 1
1. Symptoms and history
Fatigue, bleeding, diet, medication, pregnancy, blood donation and previous iron therapy are reviewed.
- 2
2. Laboratory values
Ferritin, transferrin saturation, haemoglobin and inflammation markers clarify deficiency, anaemia and context.
- 3
3. Medical counselling
Benefits, alternatives, formulation, dose and risks are discussed before treatment.
- 4
4. Infusion and observation
Iron is administered slowly through a vein. Monitoring continues during and after the infusion.
- 5
5. Follow-up
Repeat testing shows whether stores were repleted and whether the underlying cause still needs treatment.
When might symptoms improve?
Some patients feel more energy within days or weeks. Others notice little change even when lab values rise. This is not contradictory. Fatigue is multifactorial. If iron deficiency was a major driver, improvement can be noticeable. If sleep, thyroid function, infection, mental strain, inflammation or another condition dominates, iron alone will not solve the problem.
In iron-deficiency anaemia, haemoglobin and stores do not normalize overnight. The infusion provides iron, but the body still has to rebuild red blood cells and reserves. Follow-up testing and cause-focused care are therefore essential.
Safety: what should be discussed before an infusion?
Modern intravenous iron formulations are widely used, but they are still medical drugs. The European Medicines Agency notes that IV iron can cause hypersensitivity reactions and recommends observation during and for at least 30 minutes after administration: EMA Safety Guidance.
Important points include known allergies, previous reactions to IV iron, asthma, severe atopic disease, acute infection, pregnancy, inflammatory disease and any signs of iron overload. In pregnancy, IV iron requires a clear medical indication and benefit-risk assessment; the EMA states that use should be limited to situations where it is clearly necessary, usually in the second or third trimester.
Another safety point is hypophosphataemia, meaning low phosphate. Research shows that this risk can differ between IV iron formulations and has been discussed particularly with ferric carboxymaltose. A randomized trial comparing ferric carboxymaltose with ferric derisomaltose in women found clear differences in phosphate effects: HOMe aFers RCT.
Who should consider medical assessment?
Medical review is useful when fatigue, reduced tolerance, dizziness, hair shedding or restless legs occur together with risk factors such as heavy menstrual bleeding, short cycles, pregnancy or postpartum state, vegetarian or vegan diet, blood donation, gastrointestinal symptoms, known absorption problems or repeatedly low ferritin.
At Praxis Jona, the goal is not only to identify low iron, but to decide whether infusion is medically reasonable in the individual situation. You can learn more about local treatment on our iron infusion in Berlin-Mitte page. For related physician-led infusion services, see infusion therapy. For broader diagnostics, prevention and laboratory review, see prevention.
Frequently asked questions
Can iron deficiency exist with normal haemoglobin?
Yes. Haemoglobin shows whether anaemia is present. Ferritin and transferrin saturation can show low stores or limited available iron earlier.
Is an iron infusion better than tablets?
Not always. Tablets are appropriate for many patients. Infusion becomes more relevant when tablets are not tolerated, do not work, absorption is impaired, deficiency is more pronounced or faster repletion is medically justified.
Can an iron infusion help fatigue?
It can help when iron deficiency is a major driver of fatigue. Studies show benefit in selected women with low iron stores. Fatigue has many causes, so medical assessment matters.
Can iron help hair shedding?
Iron deficiency can contribute to diffuse hair shedding, but infusion is not a general hair treatment. Thyroid function, hormones, medication, stress, infection and dermatological causes may also need review.
How fast do levels rise after infusion?
It depends on baseline values, formulation, dose, ongoing blood loss and cause. Follow-up is usually interpreted after an appropriate interval, not immediately the next day.
Should the cause of iron deficiency always be investigated?
Yes. Replacing iron is only part of care. Heavy bleeding, gastrointestinal bleeding, malabsorption or inflammation should be identified and treated where possible.
Sources
- WHO guideline on use of ferritin concentrations to assess iron status
- WHO ELENA: ferritin concentrations
- PREFER trial: ferric carboxymaltose in fatigued iron-deficient women
- Intravenous iron for fatigue in non-anaemic premenopausal women
- BMJ Open systematic review on iron supplementation, fatigue and physical capacity
- Guideline review for iron deficiency in heavy menstrual bleeding
- British Society of Gastroenterology guideline for iron deficiency anaemia
- EMA recommendations for intravenous iron hypersensitivity risk
- HOMe aFers trial on hypophosphataemia after IV iron
- JAMA: prevalence of iron deficiency and iron-deficiency anaemia in US females aged 12-21
